Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers

27 Jan 2024

Abstract excerpt

MDM4 is one of the MDM protein family and is generally recognized as the key negative regulator of p53. As a cancer-promoting factor, it plays a non-negligible role in tumorigenesis and development. In this article, we analyzed the expression levels of MDM4 in pan-cancer through multiple databases. We also investigated the correlations between MDM4 expression and prognostic value, immune features, genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38281029
DOI: 10.1186/s40001-024-01684-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MDM4 was associated with poor prognosis and tumor-immune infiltration of cancersPMID 38281029Read ↗

Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer TherapySemantic proximity Read ↗

The long and the short of it: the MDM4 tail so farSemantic proximity Read ↗

Pan-cancer analysis of BLM as a prognostic and immunological marker in human tumorsSemantic proximity Read ↗

TLR4 exhibits a Pivotal Role in Immuno-Oncology through Systematic Pan-Cancer AnalysisSemantic proximity Read ↗

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and ChallengesSemantic proximity Read ↗

CD74 as a prognostic and M1 macrophage infiltration marker in a comprehensive pan-cancer analysisSemantic proximity Read ↗

The MDM2-p53 pathway revisitedSemantic proximity Read ↗

MDM4: What do we know about the association between its polymorphisms and cancer?Semantic proximity Read ↗

PLXDC1 serves as a potential prognostic marker and involves in malignant progression and macrophage polarization in colon cancerSemantic proximity Read ↗

The associations between MDM4 gene polymorphisms and cancer risk.Semantic proximity Read ↗

CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors.Semantic proximity Read ↗

Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.